MannKind Corporation

US$3.90As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:MNKDHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 6.44%
Div yield —
ROE —
Biotechnology
Beta (5Y) 1.09
PE TTM —
TSR TTM (30.23%)
Mkt cap US$1.254B
ROIC (2.34%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$5.03
28.99%
336.65%
Hold 5|1|2|5|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.08
0.08
0.09
0.10
23.46%
20.75%
35.08%
41.60%
Revenue$M
143.8
140.1
142.5
139.8
(2.09%)
(7.24%)
(4.58%)
(5.42%)
Peers (US$1.254B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.614
0.823
0.599
EBIT/Intx
1.491
1.338
1.316
Own earn%
101.27
(31.42)
(29.97)
Sh yield%
20.31
56.68
55.10
Owners
Insiders/Inst%
7.03
51.58
Short interest%
1.96
SBC / revenue%
0.50
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
9–13
$1 testx
−0.3
Incr. ROIC%
2